CGM Stock Overview
Operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals in France, other European countries, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Cegedim SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €11.15 |
| 52 Week High | €19.60 |
| 52 Week Low | €10.60 |
| Beta | 1.06 |
| 11 Month Change | -10.08% |
| 3 Month Change | -11.86% |
| 1 Year Change | -42.47% |
| 33 Year Change | -53.25% |
| 5 Year Change | -60.95% |
| Change since IPO | 10.52% |
Recent News & Updates
Recent updates
There May Be Reason For Hope In Cegedim's (EPA:CGM) Disappointing Earnings
Oct 04
Cegedim SA's (EPA:CGM) CEO Will Probably Struggle To See A Pay Rise This Year
Jun 18Getting In Cheap On Cegedim SA (EPA:CGM) Might Be Difficult
Feb 01These 4 Measures Indicate That Cegedim (EPA:CGM) Is Using Debt Extensively
Jun 27When Should You Buy Cegedim SA (EPA:CGM)?
Mar 25These 4 Measures Indicate That Cegedim (EPA:CGM) Is Using Debt Extensively
Sep 22Is Now The Time To Put Cegedim (EPA:CGM) On Your Watchlist?
Mar 03Is Cegedim SA (EPA:CGM) Trading At A 26% Discount?
Jun 04Should You Think About Buying Cegedim SA (EPA:CGM) Now?
May 20Cegedim (EPA:CGM) Seems To Use Debt Quite Sensibly
Apr 05Cegedim's (EPA:CGM) Shareholders Are Down 33% On Their Shares
Mar 21Are Investors Undervaluing Cegedim SA (EPA:CGM) By 43%?
Mar 05What Is Cegedim SA's (EPA:CGM) Share Price Doing?
Feb 12
What Is The Ownership Structure Like For Cegedim SA (EPA:CGM)?
Jan 25Cegedim SA (EPA:CGM) Delivered A Weaker ROE Than Its Industry
Jan 06What Does Cegedim's (EPA:CGM) CEO Pay Reveal?
Dec 20Does Cegedim's (EPA:CGM) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 06Cegedim's (EPA:CGM) Stock Price Has Reduced 26% In The Past Three Years
Nov 23Shareholder Returns
| CGM | FR Healthcare Services | FR Market | |
|---|---|---|---|
| 7D | -2.2% | -2.8% | -1.7% |
| 1Y | -42.5% | -11.6% | -1.9% |
Return vs Industry: CGM underperformed the French Healthcare Services industry which returned -11.6% over the past year.
Return vs Market: CGM underperformed the French Market which returned -1.9% over the past year.
Price Volatility
| CGM volatility | |
|---|---|
| CGM Average Weekly Movement | 3.5% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.4% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: CGM has not had significant price volatility in the past 3 months compared to the French market.
Volatility Over Time: CGM's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | 6,769 | Jean-Claude Labrune | www.cegedim.com |
Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals in France, other European countries, and internationally. It operates in two segments, Health Insurance, HR and e-Services; and Healthcare Professionals. The Health Insurance, HR and e-Services segment markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals.
Cegedim SA Fundamentals Summary
| CGM fundamental statistics | |
|---|---|
| Market cap | €152.89m |
| Earnings (TTM) | €2.02m |
| Revenue (TTM) | €633.98m |
75.8x
P/E Ratio0.2x
P/S RatioIs CGM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CGM income statement (TTM) | |
|---|---|
| Revenue | €633.98m |
| Cost of Revenue | €369.61m |
| Gross Profit | €264.37m |
| Other Expenses | €262.35m |
| Earnings | €2.02m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 27, 2025
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 41.70% |
| Net Profit Margin | 0.32% |
| Debt/Equity Ratio | 84.2% |
How did CGM perform over the long term?
See historical performance and comparison